Dhawan S - Search Results

1

Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system.

Wheeland RG, Dhawan S. Wheeland RG, et al. Among authors: dhawan s. J Drugs Dermatol. 2011 Jun;10(6):596-602. J Drugs Dermatol. 2011. PMID: 21637900 Clinical Trial.

2

Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.

Dhawan SS, Blyumin ML, Pearce DJ, Feldman SR. Dhawan SS, et al. J Drugs Dermatol. 2005 Mar-Apr;4(2):228-30. J Drugs Dermatol. 2005. PMID: 15776784

3

Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.

Tanghetti E, Dhawan S, Torok H, Kircik L. Tanghetti E, et al. Among authors: dhawan s. Dermatol Online J. 2007 Jul 13;13(3):1. Dermatol Online J. 2007. PMID: 18328195 Clinical Trial.

4

Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.

Tanghetti E, Kircik L, Wilson D, Dhawan S. Tanghetti E, et al. Among authors: dhawan s. J Drugs Dermatol. 2008 Jun;7(6):534-8. J Drugs Dermatol. 2008. PMID: 18561583 Clinical Trial.

5

Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.

Kircik L, Green L, Thiboutot D, Tanghetti E, Wilson D, Dhawan S, Parr L. Kircik L, et al. Among authors: dhawan s. J Drugs Dermatol. 2009 Sep;8(9):812-8. J Drugs Dermatol. 2009. PMID: 19746673 Clinical Trial.

6

Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.

Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Tanghetti E, et al. Among authors: dhawan s. J Drugs Dermatol. 2010 May;9(5):549-58. J Drugs Dermatol. 2010. PMID: 20480800 Clinical Trial.

7

Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.

Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z. Tanghetti E, et al. Among authors: dhawan s. J Drugs Dermatol. 2011 Jul;10(7):783-92. J Drugs Dermatol. 2011. PMID: 21720661 Clinical Trial.

8

A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.

Gold LS, Dhawan S, Weiss J, Draelos ZD, Ellman H, Stuart IA. Gold LS, et al. Among authors: dhawan s. J Am Acad Dermatol. 2019 Jan;80(1):168-177. doi: 10.1016/j.jaad.2018.08.020. Epub 2018 Aug 27. J Am Acad Dermatol. 2019. PMID: 30165171 Clinical Trial.

9

Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.

Moore A, Green LJ, Bruce S, Sadick N, Tschen E, Werschler P, Cook-Bolden FE, Dhawan SS, Forsha D, Gold MH, Guenthner S, Kempers SE, Kircik LH, Parish JL, Rendon MI, Rich P, Stein-Gold L, Tyring SK, Weiss RA, Nasir A, Schmitz C, Boodhoo TI, Kaoukhov A, Berk DR. Moore A, et al. Among authors: dhawan ss. J Drugs Dermatol. 2018 Sep 1;17(9):987-996. J Drugs Dermatol. 2018. PMID: 30235387 Clinical Trial.

10

Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.

Dhawan SS. Dhawan SS. Cutis. 2009 May;83(5):265-72. Cutis. 2009. PMID: 19537284 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

639 results

Search Page